Summary A prospective autopsy study of deaths of women who had been diagnosed previously as having cancer of the breast was performed between October 1986 and December 1990. During the study period 28 deaths occurred and nine of these (32%) were attributable directly to breast cancer; a figure similar to that found in our earlier retrospective study. In this study the 
In a previous study (Parham & Robertson, 1989) we found that only 29% of autopsied patients with a history of breast cancer died as a direct consequence of breast carcinoma. This was considerably lower than the results of two previous studies published by Hagemeister et al. (1980) and Cho & Choi (1980) of 92% and 84% respectively. We therefore decided to conduct a prospective study to verify our original findings.
Materials and methods
Prospective study All autopsy requests and accompanying case notes between October 1986 and December 1990 were reviewed prior to port mortem examination for women with a history of breast carcinoma. As in the previous study (Parham & Robertson, 1989) 
Discussion
The population characteristics of the cases in this study differ little from those in the previous study (Parham & Robertson, 1989 where the autopsy findings were equivocal as to the contribution that breast cancer made to death. This project and our previous study (Parham & Robertson, 1989) years observed in this study suggests that, as in our previous study (Parham & Robertson, 1989 ), our population is not unduly biased.
The accuracy of death certification has been questioned by others (Nemetz et al., 1987) : major discrepancies between antemortem and postmortem diagnoses have been documented in 7-39% of autopsies. Our study has found similar results. Where death was attributable clinically to breast cancer this was confirmed at autopsy in only 78% of cases and this figure is similar to that found in our previous study (Parham & Robertson, 1989 (Parham & Robertson, 1989) , potentially treatable conditions were not diagnosed and remained untreated. Clearly this is important as it raises the possibility that in a wider context some patients may be receiving inappropriate terminal care when they have potentially treatable (and even curable) disease. Our findings are derived solely from autopsies requested by hospital practitioners. The diagnostic accuracy of general practitioners is unlikely to be better and indeed may be poorer due to the lack of facilities for the investigation of patients outside hospital. This is of concern as there is a greater tendency for patients to receive terminal care at home, where elimination of treatable terminal illness is not possible and inappropriate terminal care may be given.
The inaccuracy of information regarding breast cancer mortality is disturbing, particularly with regard to determining the efficacy of breast cancer screening. Indeed in the Malmo breast screening trial (Andersson et al., 1988) , where approximately 76% of patients deaths underwent autopsy it was not rare to find an alternative cause of death in patients who were clinically thought to have died of breast cancer. If the true mortality of non-screened breast cancer remains unclear then the results from any study of screen detected tumours are bound to be questionable, although, if the tendency is to over-attribute breast cancer as a cause of death, this would tend to mask any real reduction in mortality attributable to screening.
It is disappointing that there was a slight decrease in the proportion of breast cancer autopsies between our study published previously and this one (4.5%, 85 autopsies out of 1987 registered breast cancers deaths over a 163 month period, compared with 3.7%, 28 autopsies out of 754 registered breast cancer over a period of 51 months). Indeed if the five autopsies from the breast cancer screening trial are excluded the drop in the proportion of cases would have been greater (3.2%). It is discouraging that only five of the 36 deaths, in patients diagnosed with breast cancer as part of the UK Early Detection of Breast Cancer Screening Trial, came to autopsy despite considerable efforts having been made to persuade general practitioners and clinicians as to the value of the study. At the start all General Practitioners and Hospital Consultants in the Dundee area were contacted regarding the importance of obtaining an autopsy specifically on these patients. They all received written details of the study and many were contacted informally. The poor autopsy rate may in part be due to a reluctance on behalf of doctors to further distress relatives at the time of the bereavement and possibly the perceived financial and administrative costs incurred by a General Practitioner in arranging an autopsy in spite of all transport costs being borne by the hospital service. This contrasts the high autopsy rate for HIV deaths in our area where there is a high level of clinical concern by the clinicians.
The decline in autopsy rates in general is of concern and the reasons for this have been discussed in detail elsewhere (Nemetz et al., 1987) . Nevertheless the autopsy plays a critical role in modern medicine being a definitive method of quality control and audit. The results provide accurate mortality data for clinical research, treatment, public health planning. It is worrying that the introduction of resource management and clinical budgeting may further reduce the number of autopsies, where there is clear evidence to suggest that structured collection of autopsy data is necessary for medical research.
